Larry Slomowitz, DPM
Foot Surgery · Westlake Village, CANPI 1417145525
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 14 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 11 manufacturers, the largest accounting for just 16.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $383 and has fallen 67.4% since, to $125 in 2025.
Across 14 payments — averaging $101.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$234
- Treace Medical Concepts, Inc.$176
- Acera Surgical, Inc.$158
- Linvatec Corporation$155
- Smith+Nephew$125
- Paratek Pharmaceuticals, Inc.$125
- plus $446 from 5 others
What the payments were for
- Food & beverage$1,419100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 2 | $234 |
| Treace Medical Concepts, Inc. | 1 | $176 |
| Acera Surgical, Inc. | 1 | $158 |
| Linvatec Corporation | 2 | $155 |
| Smith+Nephew | 1 | $125 |
| Paratek Pharmaceuticals, Inc. | 1 | $125 |
| AbbVie | 1 | $124 |
| Bioventus LLC | 1 | $110 |
| Stryker | 1 | $109 |
| Cardiovascular Systems Inc. | 1 | $77 |
| Orthofix Medical, Inc. | 2 | $26 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- KRYSTEXXA$234
- Lapiplasty System$176
- Restrata Wound Matrix$158
- Grafix$125
- GRAFIX PL$125
- Stravix$125
- NUZYRA$125
- DALVANCE$124
- BioBrace 23mm$111
- Exogen Ultrasound Bone Healing System$110
- PROstep$109
How this compares
$1,419 in reported general payments places this provider in the 70th percentile of 71 foot surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JubliaEfinaconazole | 12 | $11,233 |
| Clotrimazole | 58 | $1,338 |
| Ketoconazole | 12 | $336 |
| Cephalexin | 15 | $236 |
| Meloxicam | 30 | $100 |
Paid to pharmacies, not to this prescriber.
Other foot surgery in Westlake Village
- Alexander ReyzelmanSan Francisco$137K
- Helen ShnolBeverly Hills$22K
- Benedict ChingFountain Valley$19K
- Zachary KramerEncinitas$14K
- Tara HarringtonElk Grove$12K
- Jack MorganMonterey Park$11K
- Jaehyun KimSunnyvale$7K
- Ingrid EdelmanSan Diego$6K
- Spencer SterlingBellflower$5K
- Beverly SpursConcord$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.